Prophylactic treatment with novel forms of allergen-laden virus like-nanoparticles (VNP) induces specific tolerance in a mouse model of allergy.
B. Kratzer, C. Köhler, S. Hofer, U. Smole, D. Trapin, J. Iturri, D. Pum, P. Kienzl, A. Elbe-Bürger, P. Gattinger, I. Mittermann, B. Linhart, Y. Dorofeeva, B. Jahn-Schmid, A. Neunkirchner, R. Valenta, W. F. Pickl, Vienna, Austria.
The work has been published in
Allergy. 2018 Jul 23. doi: 10.1111/all.13573. [Epub ahead of print]
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model. www.ncbi.nlm.nih.gov/pubmed/30035810
Please find more information at the website of the congress: https://www.eci2018.org/home/
zurück zu: CePII